Shantel
Key Takeaways
- TriNetX has appointed Jason Meggs as its new Chief Financial Officer (CFO).
- Meggs’ prior experience includes roles at Syneos Health, Arthur Anderson, Deloitte, and Quintiles Transnational.
- His appointment comes as TriNetX continues to expand its global reach.
Appointment of New CFO
TriNetX, a global network of healthcare organizations focusing on real-world research to hasten the development of new therapies, announced the appointment of Jason Meggs as its new Chief Financial Officer (CFO). Gadi Lachman, CEO and Founder of TriNetX, expressed confidence that Meggs’ financial experience, particularly within the life sciences industry, will be greatly beneficial as the company continues to grow internationally.
Meggs most recently served as the CFO at Syneos Health, leading the finance and accounting teams while also being responsible for corporate strategy, information technology, and global deal management. His career history includes a financial auditor role at Arthur Anderson and Deloitte, as well as several positions at Quintiles Transnational (now IQVIA), including Global Vice President of Internal Audit. He is a licensed Certified Public Accountant in North Carolina.
Looking Ahead
Meggs expressed his excitement about joining TriNetX and contributing to the company’s mission of using real-world data to drive scientific discoveries that improve patient lives. He emphasized the critical importance of the CFO role in fast-growing companies like TriNetX and voiced eagerness to collaborate with his new colleagues as the organization continues to lead in real-world data and evidence generation.
About TriNetX, LLC
TriNetX is a global network of healthcare organizations and life sciences companies focused on driving real-world research to accelerate the development of new therapies. The company provides a self-service platform compliant with HIPAA, GDPR, and LGPD, and offers federated EHR datasets and consulting partnerships. This empowers its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enhance real-world evidence generation.
